Exchange Traded Concepts, LLC Arvinas, Inc. Transaction History
Exchange Traded Concepts, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 6,659 shares of ARVN stock, worth $123,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,659
Previous 4,861
36.99%
Holding current value
$123,990
Previous $129,000
27.13%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARVN
# of Institutions
230Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$130 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$125 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$117 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$71.8 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$51.8 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $991M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...